Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04289363 · ClinicalTrials.gov registry record
Emergency Department Outcomes for Patients With Opioid Use Disorder
A clinical trial of Opioid Use Disorder, sponsored by NYU Langone Health.
- Completed
- Registry status
- 53
- Enrollment target
- 2
- Study locations
NCT04289363 is a study of Opioid Use Disorder that has completed, run by NYU Langone Health. The registered enrollment target is 53 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT04289363, a study of Opioid Use Disorder, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
- 2
- Study locations
Study Summary
Using mixed methods and triangulating multiples sources of data collected over the course of the parent (CTN-0079 - NCT03544112) and the ancillary studies to evaluate the feasibility, acceptability, sustainability and impact of the emergency department (ED)-initiated Buprenorphine (BUP) clinical program and implementation facilitation strategy and identify factors influencing diffusion and effectiveness.
Conditions Studied
Interventions
- BEHAVIORAL Clinical program implementation
Study Locations (2)
New Hampshire
- Catholic Medical Center - Manchester
New York
- Bellevue Hospital Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2020-11-25 |
| Est. Completion | 2022-02-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04289363
The ClinicalTrials.gov registry entry for NCT04289363 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Clinical program implementation is the first listed.
NCT04289363 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Hampshire, New York.
Frequently Asked Questions
What is clinical trial NCT04289363 about?
NCT04289363 is a clinical study titled "Emergency Department Outcomes for Patients With Opioid Use Disorder". Using mixed methods and triangulating multiples sources of data collected over the course of the parent (CTN-0079 - NCT03544112) and the ancillary studies to evaluate the feasibility, acceptability, sustainability and impact of the emergency department (ED)-initiated Buprenorphine (BUP) clinical pro...
What is the current status of trial NCT04289363?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2020-11-25. Estimated completion is 2022-02-18.
What conditions does trial NCT04289363 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT04289363?
The interventions under investigation include: Clinical program implementation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04289363?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04289363 being conducted?
This trial has 2 study locations across New Hampshire, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.